plicamycin has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, Y; Li, Z; Miao, J; Wei, C; Yan, Q; Zhang, W; Zhao, C; Zhou, Q | 1 |
| Christensen, MA; Lehman, A; Philipsen, S; Qing, H; Song, W; Zhou, W | 1 |
2 other study(ies) available for plicamycin and Alzheimer Disease
| Article | Year |
|---|---|
Mithramycin A Alleviates Cognitive Deficits and Reduces Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Animals; Cerebral Cortex; Cognition Disorders; Disease Models, Animal; Hippocampus; Male; Mice; Mice, Transgenic; Plicamycin; Sp1 Transcription Factor | 2016 |
Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Base Sequence; Cell Line; Chromosome Mapping; Cloning, Molecular; DNA; Endopeptidases; Humans; Mice; Mice, Knockout; Molecular Sequence Data; Plicamycin; Promoter Regions, Genetic; Protein Processing, Post-Translational; Rats; Sequence Deletion; Sp1 Transcription Factor; Transcription, Genetic; Up-Regulation | 2004 |